|
1
|
25
|
7yq3B |
Human insulin receptor bound with a43 dna aptamer and insulin |
|
3
|
21
|
7yq5A |
Human insulin receptor bound with a62 dna aptamer and insulin |
|
4
|
21
|
7qgfAAA |
Cubic insulin sad phasing at 14.2 kev |
|
7
|
29
|
7qgfBBB |
Cubic insulin sad phasing at 14.2 kev |
|
4
|
25
|
7u6eB |
Head region of insulin receptor ectodomain (a-isoform) bound to the non-insulin agonist im462 |
|
5
|
18
|
7u6eG |
Head region of insulin receptor ectodomain (a-isoform) bound to the non-insulin agonist im462 |
|
168
|
594
|
7u6eE |
Head region of insulin receptor ectodomain (a-isoform) bound to the non-insulin agonist im462 |
|
5
|
21
|
7u6eA |
Head region of insulin receptor ectodomain (a-isoform) bound to the non-insulin agonist im462 |
|
4
|
21
|
7s4yA |
Serial macromolecular crystallography at alba synchrotron light source - insulin |
|
6
|
30
|
7s4yB |
Serial macromolecular crystallography at alba synchrotron light source - insulin |
|
2
|
30
|
7eljB |
Prion derived tetrapeptide stabilizes thermolabile insulin via conformational trapping |
|
5
|
21
|
7eljA |
Prion derived tetrapeptide stabilizes thermolabile insulin via conformational trapping |
|
5
|
22
|
6verB |
Human insulin analog: [glub10,tyrb20]-doi |
|
5
|
21
|
6vesA |
Human insulin analog: [glub10,hisa8,arga9]-doi |
|
5
|
22
|
6vesB |
Human insulin analog: [glub10,hisa8,arga9]-doi |
|
6
|
20
|
6verA |
Human insulin analog: [glub10,tyrb20]-doi |
|
5
|
21
|
6kh8A |
Solution structure of zn free bovine pancreatic insulin in 20% acetic acid-d4 (ph 1.9) |
|
4
|
30
|
6kh8B |
Solution structure of zn free bovine pancreatic insulin in 20% acetic acid-d4 (ph 1.9) |
|
4
|
30
|
6khaB |
Solution structure of bovine insulin amyloid intermediate-2 |
|
1
|
21
|
6khaA |
Solution structure of bovine insulin amyloid intermediate-2 |
|
5
|
30
|
6kh9B |
Solution structure of bovine insulin amyloid intermediate-1 |
|
2
|
21
|
6kh9A |
Solution structure of bovine insulin amyloid intermediate-1 |
|
5
|
20
|
6vetA |
Human insulin analog: [glub10,hisa8,arga9,tyrb20]-doi |
|
5
|
22
|
6vetB |
Human insulin analog: [glub10,hisa8,arga9,tyrb20]-doi |
|
5
|
21
|
6nwvA |
Insulin lispro analog |
|
7
|
27
|
6nwvB |
Insulin lispro analog |
|
9
|
28
|
6tyhB |
Four-disulfide insulin analog a22/b22 |
|
5
|
22
|
6tyhA |
Four-disulfide insulin analog a22/b22 |
|
3
|
30
|
1jcoB |
Solution structure of the monomeric [thr(b27)->pro,pro(b28)->thr] insulin mutant (pt insulin) |
|
3
|
21
|
1jcoA |
Solution structure of the monomeric [thr(b27)->pro,pro(b28)->thr] insulin mutant (pt insulin) |
|
3
|
21
|
5t7rA |
A6-a11 trans-dicarba human insulin |
|
8
|
27
|
5mam1 |
Human insulin in complex with serotonin |
|
6
|
21
|
5mam0 |
Human insulin in complex with serotonin |
|
5
|
29
|
6ck2B |
Insulin analog containing a yb26w mutation |
|
5
|
21
|
6ck2A |
Insulin analog containing a yb26w mutation |
|
7
|
29
|
5azzB |
Crystal structure of seleno-insulin |
|
4
|
21
|
5btsA |
Structural and biophysical characterization of a covalent insulin dimer formed during storage of neutral formulation of human insulin |
|
6
|
30
|
5btsB |
Structural and biophysical characterization of a covalent insulin dimer formed during storage of neutral formulation of human insulin |
|
5
|
28
|
4ungB |
Human insulin b26asn mutant crystal structure |
|
6
|
30
|
4f1dB |
Human insulin |
|
4
|
21
|
4f51A |
Human insulin |
|
6
|
30
|
4f8fB |
Human insulin |
|
6
|
30
|
4f1bB |
Human insulin |
|
4
|
21
|
4f1gA |
Human insulin |
|
4
|
21
|
4f8fA |
Human insulin |
|
4
|
21
|
4eynA |
Human insulin |
|
4
|
21
|
4ewzA |
Human insulin |
|
4
|
21
|
4f0nA |
Human insulin |
|
4
|
21
|
4ewwA |
Human insulin |
|
4
|
21
|
4ex0A |
Human insulin |
